Müller OA - Search Results

1

Inhibition of interleukin-2-mediated lymphocyte activation in patients with Cushing's syndrome: a comparison with hypocortisolemic patients.

Sauer J, Stalla GK, Müller OA, Arzt E. Sauer J, et al. Among authors: muller oa. Neuroendocrinology. 1994 Feb;59(2):144-51. doi: 10.1159/000126651. Neuroendocrinology. 1994. PMID: 8127403

2

Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures.

Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK. Arzt E, et al. Among authors: muller oa. J Clin Invest. 1992 Nov;90(5):1944-51. doi: 10.1172/JCI116072. J Clin Invest. 1992. PMID: 1331177 Free PMC article.

3

CRH in Cushing's syndrome.

Müller OA, Stalla GK, von Werder K. Müller OA, et al. Horm Metab Res Suppl. 1987;16:51-8. Horm Metab Res Suppl. 1987. PMID: 2832289

4

In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.

Auernhammer CJ, Riepl RL, Schopohl J, Lehnert P, Müller OA, Stalla GK. Auernhammer CJ, et al. Among authors: muller oa. Neuroendocrinology. 1994 Jul;60(1):16-22. doi: 10.1159/000126715. Neuroendocrinology. 1994. PMID: 8090278

5

Octreotide exerts different effects in vivo and in vitro in Cushing's disease.

Stalla GK, Brockmeier SJ, Renner U, Newton C, Buchfelder M, Stalla J, Müller OA. Stalla GK, et al. Among authors: muller oa. Eur J Endocrinol. 1994 Feb;130(2):125-31. doi: 10.1530/eje.0.1300125. Eur J Endocrinol. 1994. PMID: 8130885

6

Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro.

Auernhammer CJ, Renner U, Müller OA, Stalla J, Stalla GK. Auernhammer CJ, et al. Among authors: muller oa. Neuroendocrinology. 1993 Jun;57(6):1019-27. doi: 10.1159/000126466. Neuroendocrinology. 1993. PMID: 8232760

7

Secretion of polypeptide growth factors by human nonfunctioning pituitary adenoma cells in culture.

Renner U, Mojto J, Arzt E, Lange M, Stalla J, Müller OA, Stalla GK. Renner U, et al. Among authors: muller oa. Neuroendocrinology. 1993 May;57(5):825-34. doi: 10.1159/000126441. Neuroendocrinology. 1993. PMID: 8413819

8

Acute adrenocortical stimulation by recombinant gamma interferon in human controls.

Holsboer F, Stalla GK, von Bardeleben U, Hammann K, Müller H, Müller OA. Holsboer F, et al. Among authors: muller oa, muller h. Life Sci. 1988;42(1):1-5. doi: 10.1016/0024-3205(88)90617-0. Life Sci. 1988. PMID: 2826952 Clinical Trial.

9

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment.

von Bardeleben U, Stalla GK, Müller OA, Holsboer F. von Bardeleben U, et al. Among authors: muller oa. Biol Psychiatry. 1988 Nov;24(7):782-6. doi: 10.1016/0006-3223(88)90254-5. Biol Psychiatry. 1988. PMID: 2852510

10

Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.

Müller OA, Stalla GK, von Werder K. Müller OA, et al. J Clin Endocrinol Metab. 1983 Jul;57(1):227-9. doi: 10.1210/jcem-57-1-227. J Clin Endocrinol Metab. 1983. PMID: 6304135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters